366 related articles for article (PubMed ID: 25543222)
1. [Lower doses of tolvaptan in hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion].
Sánchez Sobrino P; Fernández Catalina P; Lorenzo Solar M; Rego Iraeta A
Med Clin (Barc); 2015 Aug; 145(3):138-9. PubMed ID: 25543222
[No Abstract] [Full Text] [Related]
2. Low-dose tolvaptan for the treatment of hyponatremia in the syndrome of inappropriate ADH secretion (SIADH).
Harbeck B; Lindner U; Haas CS
Endocrine; 2016 Sep; 53(3):872-3. PubMed ID: 26961548
[No Abstract] [Full Text] [Related]
3. Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials.
Gralla RJ; Ahmad F; Blais JD; Chiodo J; Zhou W; Glaser LA; Czerwiec FS
Cancer Med; 2017 Apr; 6(4):723-729. PubMed ID: 28251822
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of long-term tolvaptan treatment in a patient with SCLC and SIADH.
Bordi P; Tiseo M; Buti S; Regolisti G; Ardizzoni A
Tumori; 2015 Apr; 101(2):e51-3. PubMed ID: 25702667
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double blinded, placebo-controlled trial to evaluate the efficacy and safety of tolvaptan in Chinese patients with hyponatremia caused by SIADH.
Chen S; Zhao JJ; Tong NW; Guo XH; Qiu MC; Yang GY; Liu ZM; Ma JH; Zhang ZW; Gu F
J Clin Pharmacol; 2014 Dec; 54(12):1362-7. PubMed ID: 24906029
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Tolvaptan in Korean Patients with Hyponatremia Caused by the Syndrome of Inappropriate Antidiuretic Hormone.
Han SW; Yi JH; Kang KP; Kim HY; Kim SW; Choi HY; Ha SK; Kim GH; Kim YW; Jeong KH; Shin SK; Kim HJ
J Korean Med Sci; 2018 Apr; 33(15):e112. PubMed ID: 29629516
[TBL] [Abstract][Full Text] [Related]
7. Uric acid levels with tolvaptan treatment for syndrome of inappropriate antidiuretic hormone secretion.
Nagamine T
Endocrine; 2024 Mar; 83(3):826-827. PubMed ID: 37982946
[No Abstract] [Full Text] [Related]
8. Tolvaptan for SIADH in Myelodysplastic Syndrome with Blast Crisis.
Mali P; Muduganti SR; Mujibur R; Murali N
WMJ; 2015 Apr; 114(2):66-8. PubMed ID: 26756059
[TBL] [Abstract][Full Text] [Related]
9. Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan.
Morris JH; Bohm NM; Nemecek BD; Crawford R; Kelley D; Bhasin B; Nietert PJ; Velez JCQ
Am J Kidney Dis; 2018 Jun; 71(6):772-782. PubMed ID: 29478867
[TBL] [Abstract][Full Text] [Related]
10. Effect of tolvaptan on hyponatremia in a dog with syndrome of inappropriate secretion of antidiuretic hormone.
Yamamoto H; Kimura K; Horikirizono H; Tamura Y; Kambayashi S; Baba K; Okuda M; Mizuno T; Igase M
J Vet Med Sci; 2023 Oct; 85(10):1047-1051. PubMed ID: 37587049
[TBL] [Abstract][Full Text] [Related]
11. [The use of tolvaptan in a case of severe hyponatriemia in SIADH during meningitis].
Rollino C; Balbiano R; Caramello P; Roccatello D
G Ital Nefrol; 2013; 30(6):. PubMed ID: 24402662
[TBL] [Abstract][Full Text] [Related]
12. Prompt efficacy of tolvaptan in treating hyponatremia of syndrome of inappropriate secretion of antidiuretic hormone (SIADH) closely associated with rupture of a gastric artery aneurysm.
Yamashita T; Yoshida M; Yamada H; Asano T; Aoki A; Ikoma A; Kusaka I; Kakei M; Ishikawa SE
Intern Med; 2014; 53(8):845-9. PubMed ID: 24739604
[TBL] [Abstract][Full Text] [Related]
13. Once-weekly tolvaptan for chronic symptomatic hyponatremia due to syndrome of inappropriate secretion of anti-diuretic hormone.
Adhiyaman V; Chattopadhyay I; Williams M
J Am Geriatr Soc; 2014 Jul; 62(7):1405-6. PubMed ID: 25039522
[No Abstract] [Full Text] [Related]
14. Effect of single-dose of tolvaptan in neurocritical patients with hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion.
Llompart-Pou JA; Pérez-Bárcena J; Novo M; Raurich JM
Med Intensiva; 2017 Nov; 41(8):501-503. PubMed ID: 28087091
[No Abstract] [Full Text] [Related]
15. Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in Sweden.
Jamookeeah C; Robinson P; O'Reilly K; Lundberg J; Gisby M; Ländin M; Skov J; Trueman D
BMC Endocr Disord; 2016 May; 16(1):22. PubMed ID: 27184496
[TBL] [Abstract][Full Text] [Related]
16. Tolvaptan for hyponatremia.
Hoorn EJ; Zietse R
N Engl J Med; 2007 Mar; 356(9):961; author reply 962-3. PubMed ID: 17338052
[No Abstract] [Full Text] [Related]
17. A retrospective study on tolvaptan prescription in clinical practice in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH) using the Japanese claims database.
Hagiwara D; Matsukawa M; Tasaki J; Nakamura Y; Arima H
Endocr J; 2023 Dec; 70(12):1195-1205. PubMed ID: 37914256
[TBL] [Abstract][Full Text] [Related]
18. Tolvaptan for hyponatremia.
Ozkan C; Kirkpantur A; Arici M
N Engl J Med; 2007 Mar; 356(9):962; author reply 962-3. PubMed ID: 17338053
[No Abstract] [Full Text] [Related]
19. Tolvaptan for hyponatremia.
Weise WJ; Rimmer JM; Hood VL
N Engl J Med; 2007 Mar; 356(9):961; author reply 962-3. PubMed ID: 17329708
[No Abstract] [Full Text] [Related]
20. Tolvaptan.
Dubois EA; Rissmann R; Cohen AF
Br J Clin Pharmacol; 2012 Jan; 73(1):9-11. PubMed ID: 21623874
[No Abstract] [Full Text] [Related]
[Next] [New Search]
